How a major discovery can become a public health failure when used subotptimally: lessons from early nirsevimab implementation
Our clinical insights and reflections aim to inspire deeper engagement among policymakers, health agencies, and clinicians to better adapt and integrate RSV preventive strategies-maximizing benefit not only for susceptible infants, but for society at large. In a world of finite healthcare resources, optimizing both the reach and the value of such essential interventions is imperative, given the multitude and diversity of health needs our society is facing.
Authors
- Danilo Buonsenso (ORCID: https://orcid.org/0000-0001-8567-2639)
- Rosa Morello (ORCID: https://orcid.org/0000-0002-2372-084X)
- Antoni Soriano‐Arandes (ORCID: https://orcid.org/0000-0001-9613-7228)
- Carolina Gentili
- Aida Perramon‐Malavez (ORCID: https://orcid.org/0000-0002-6057-5127)
- Marta Bellorofonte
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- Vall d'Hebron Institut de Recerca (ES)
- Hospital de Palamós (ES)
- Universitat Politècnica de Catalunya (ES)
Publication Details
- Journal
- The Italian Journal of Pediatrics/Italian journal of pediatrics
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1186/s13052-025-02147-9
- Citations
- 1
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 1.35